Gut bugs may decide if your statin works
NCT ID NCT04098003
First seen Jun 25, 2026 · Last updated Jul 10, 2026 · Updated 3 times
Summary
This study looks at how the bacteria living in your gut might change how well the cholesterol-lowering drug rosuvastatin (Crestor) works. Researchers will give healthy volunteers either the drug or a placebo for eight weeks and track changes in gut bacteria and cholesterol levels. The goal is to understand why some people respond better to statins than others.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Rosuvastatin (Crestor)
- What this could lead to
- If successful, this could help doctors predict who will benefit most from statins based on their gut bacteria.
- What could go wrong
- This is a small, early-stage study in healthy people, not those with high cholesterol. Results may not apply to patients or lead to immediate changes in treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
45 people
The number who actually took part.
- Started
-
Feb 2020
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Participant is capable of giving informed consent 2. Participant is aged 18 to 65 years. The gut microbiome has been shown to change gradually with time, although there is no cut-off in age when this occurs. Exclusion Criteria: 1. Participants with cardiovascular disease such as a history of heart failure (New York Heart Association class II-IV), myocardial infarction, stroke, coronary artery bypass graft, hypertension, and hyperlipidemia as these conditions are associated with altered gut microbiome composition.74 Hypertension is defined as blood pressure greater than 160/110 or on any anti-hypertensive medications. LDL-C \>190 mg/dl or \<100 mg/dl and triglycerides \> 400 mg/dl. 2. Participants with a history of cancer. 3. Kidney disease (serum creatinine \>1.5 mg/dl). 4. Liver dysfunction (alanine aminotransferase \> 2 times the upper limit of normal). 5. Diabetes mellitus (DM) - Diabetes itself may affect the gut microbiome although this has not been extensively studied. In addition to a prior diagnosis of diabetes mellitus other than that related to pregnancy, a fasting glucose level of greater than 125mg/dL will be used to exclude participation. 6. Clinical diagnosis of hypothyroidism 7. History of inflammatory disorders of the intestinal tract (i.e. IBD, celiac sprue). 8. Use of antibiotics in the prior 6 months. 9. Use of pre-, pro-, or synbiotics. 10. Chronic medication use (including over the counter medications and herbal supplements) with the exception of oral contraceptives. Since we are evaluating the impact of rosuvastatin on the gut microbiome we would like to exclude the potential impact of confounding medications. 11. Current smoker. The effect of smoking on the microbiome of the gut is unknown. 12. Known history of alcohol or substance abuse. 13. Body Mass Index (BMI) \<18.5 or \>30 kg/m2. Volunteers with BMI below normal will be excluded to prevent inclusion of subjects with a subclinical systemic disease that may influence the gut microbiome. Volunteers with moderate or severe obesity will be excluded as obesity may be associated with altered gut microbiome composition.31 14. Unable to abstain from consumption of illicit drugs during the study period. 15. Prior bowel resection surgery other than appendectomy. It is unknown how prior bowel resection surgery may influence the microbiome composition; hence we will exclude these participants. 16. Baseline bowel frequency less than every 2 days or greater than 3 times daily. Normal bowel frequency is every 3rd day to 3 times per day. Although unknown, stool frequency could be related to the microbiome composition. To avoid the need for use of antidiarrheal medications or laxatives, which themselves could alter the microbiome composition, these patients will be excluded. 17. Participant has experienced diarrhea within the two weeks prior to entry. Diarrhea is defined as a change in bowel habits with an increased frequency or loose stools such that the stool could not be lifted with a fork. 18. Vegans and Vegetarians. 19. Known intolerance to statin medications. 20. Unwilling to obtain from grapefruit containing foods or drinks. 21. Pregnant women. To avoid any risk to an unborn fetus from study drug exposure. 22. Refusal to use two medically accepted method of birth control while participating in the study, such as a barrier method, hormonal contraceptives, implanted birth control devices, permanent methods (such as a vasectomy), and/or abstinence. 23. Nursing mothers 24. Any condition that the investigator feels may limit the volunteer's ability to complete the study protocol.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy volunteers are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania
Phildelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists probe the nerve highways behind strength gains
- New syphilis test kits put to the test with donated blood
- Can a copy of a blockbuster arthritis drug match the original? scientists test it in healthy people
- Novo nordisk tests Brand-New molecule in humans for the first time
- New sedative candidate goes Head-to-Head with propofol in early human test
- Can a Room-Temperature dairy drink build muscle?